Human germline genome editing and broad societal consensus

Françoise Baylis ()
Additional contact information
Françoise Baylis: Professor and Canada Research Chair in Bioethics and Philosophy, Novel Tech Ethics, Faculty of Medicine, Dalhousie University

Nature Human Behaviour, 2017, vol. 1, issue 6, 1-3

Abstract: Should human genome editing be limited to somatic cells, or should germline genome editing also be permitted? Should (apparently) permissible human genome editing be limited to therapeutic purposes, or should enhancement purposes also be permitted? Who decides, and on what basis?

Date: 2017
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.nature.com/articles/s41562-017-0103 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nathum:v:1:y:2017:i:6:d:10.1038_s41562-017-0103

Ordering information: This journal article can be ordered from
https://www.nature.com/nathumbehav/

DOI: 10.1038/s41562-017-0103

Access Statistics for this article

Nature Human Behaviour is currently edited by Stavroula Kousta

More articles in Nature Human Behaviour from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().